ATPC Agape ATP Corp. Total Asset Value of Company

ATPC (agapeatpgroup.com) - company brandmark

This price chart for Agape ATP Corporation (ATPC) total assets, valued at 25.00, reflects the dynamics of a business driven by the development of personalized therapy and the wellness segment in Asia. However, expansion is being hindered by geopolitical tensions that threaten component logistics and patent law. The company's stability is supported by implemented AI systems that automate patient monitoring and optimize drug delivery.

ATPC (Agape ATP) Company Total Assets history from 02/21/2024 to 10/31/2026

Analytical breakdowns and data insights for company agapeatpgroup.com (ATPC)

- price and consensus price forecast:
Stock Quotes Agape ATP|ATPC - Price Target Chart
- market capitalization data:
Market Valuation Agape ATP Corporation|ATPC - Enterprise Value
- issuer book value statistics:
Accounting Value of a Share Agape ATP|ATPC - Book Capitalization|Market Capitalization to Book Value Ratio agapeatpgroup.com|ATPC - Aggregate Company Assets
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Agape ATP Corporation|ATPC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Agape ATP|ATPC - Company Aggregate Debts|Debts to Book Capitalization Agape ATP Corporation|ATPC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Agape ATP|Quick Liquidity Indicator agapeatpgroup.com
- net income and valuation multiples indicators:
ATPC - Net Profit
Fundamental valuation:Agape ATP Corporation
Manufactured products of Agape ATP Corp

Agape ATP Corporation (ATPC) is expanding its wellness business across Asian markets through organic growth and partnerships, avoiding risky mergers. By analyzing the company's overall resource structure, an investor can determine the total asset value reverse-calculated via return on assets (ROA), which allows for an assessment of capital management efficiency and confirms the fundamental stability of its conservative development strategy.

Key competitors

Cumulative Company Assets ascendispharma.com|Aggregate Company Assets Madrigal Pharmaceuticals, Inc.|Corcept Therapeutics Inc. - Total Asset Value of Company|Company Total Assets RYTM|AKRO (Akero Corp) - Aggregate Asset Value|Company Total Assets MTSR (Metsera Inc)|Company Total Assets moonlaketx.com MLTX|CRNX - Aggregate Company Assets|Aggregate Asset Value NAMS (NewAmsterdam Pharma Company)|Soleno (SLNO) - Aggregate Company Assets|Cumulative Company Assets Amicus Corp|ETNB (89bio, Inc.) - Company Total Assets|Company Total Assets agios.com|Cumulative Company Assets GPCR (Structure Therapeutics Inc.)|MDXG (MiMedx Group Inc) - Aggregate Asset Value|Aggregate Company Assets Rezolute Corp RZLT|LXRX - Cumulative Company Assets|MBX Biosciences Inc - Company Total Assets|Company Assets altimmune.com|AARD (Aardvark Therapeutics) - Cumulative Company Assets|SGMT: Aggregate Business Assets|BIOA (BioAge Labs Inc.) - Company Total Assets|Company Total Assets Biomea Fusion Corp|Company Total Assets QNCX|Aggregate Company Assets GUTS (fractyl.com)|Aggregate Company Assets vTv Therapeutics VTVT|Pluristem Therapeutics (PLUR) - Company Assets|SYBX - Aggregate Company Assets|LPCN: Aggregate Company Assets|MTNB: Company Total Assets|SPRB - Company Total Asset Base|Aggregate Company Assets Galecto|Carmell Corp. (CTCX) - Company Total Asset Base|Aggregate Company Assets Lumos Pharma Corp (LUMO)|Cumulative Company Assets Organovo Corp ONVO|Company Total Assets RDUS (Radius Recycling, Inc.)